Novartis to buy US gene therapy group AveXis for $8.7 bn
newsare.net
Swiss pharmaceuticals giant Novartis announced Monday it will buy US gene therapy company AveXis for $8.7 billion (7.1 billion euros).Novartis to buy US gene therapy group AveXis for $8.7 bn
Swiss pharmaceuticals giant Novartis announced Monday it will buy US gene therapy company AveXis for $8.7 billion (7.1 billion euros). Read more